Antigen depots
Nature Immunology
November 21, 2011
The effects of type 1 interferon (IFN), which is normally produced by mammalian cells following viral infection, are unexpectedly inhibited in specialized immune cells during vesicular stomatitis virus (VSV) infection, according to a report published in Nature Immunology. This finding could have implications for vaccine design. Usp18 is a host protein that dampens type 1 interferon signaling. Karl Sebastian Lang and colleagues show that specialized cells in the spleen, called metallophilic macrophages, express high amounts of Usp18. By inhibiting IFN, Usp18 allows viral replication in these cells, which is necessary for the generation of neutralizing antibodies and antiviral T cells. Interfering with the ‘antigen depot’ function of these cells leads to failure of the adaptive immune responses against VSV and viral dissemination to the central nervous system. Targeting vaccines to metallophilic macrophages could increase the chances of generating a protective adaptive immune response.
doi: 10.1038/ni.2169
Research highlights
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature